-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Guidance: According to a recently released model by the Centers for Disease Control and Prevention (CDC), HPV has overtaken cervical cancer to become the most common HPV-related cancer in the United States
Merck andCoThis oral and head and neck cancer indicationisis is accelerated based on the effectiveness of Gardasil9 in the prevention of HPV-related genital diseasesThe ongoing approval of the indications may depend on the validation and description of clinical benefits in validation trials, which are currently under wayDr Alain Luxembourg, director of clinical research at the's Mercado Research Laboratory, said: "At Mercadon, for more than 20 years, efforts to help prevent certain HPV-related cancers have been a priorityToday's approval to prevent HPV-related pharynx and other head and neck cancers represents a major step forward in Mershadon's mission to help reduce the number of men and women affected by certain HPV-related cancers"
Gardasil9 is a human papillomavirus (HPV) vaccine for women aged 9-45 years:(1) for the prevention of cervical, vulva, vagina, anus, pharynx and other cervical and other cervical cancers caused by seven high-risk types of HPV (16, 18, 31, 33, 45, 52, 58);(2) is used to prevent 9 types of HPV (6, 11, 16, 18, 31, 33, 45, 52, 58) caused by cervical, vulva, anal cancer precancerous lesions or abnormal increase diswelling;Gardasil9 is suitable for men aged 9-45 years:(1) for the prevention of, pharynx and other head and neck cancers caused by 7 types of high-risk HPV (16, 18, 31, 33, 45, 52, 58);(2) is used to prevent pre-anal cancer lesions or abnormal increases caused by 9 types of HPV (6, 11, 16, 18, 31, 33, 45, 52, 58), and(3) for the prevention of genital warts caused by 2 types of low-risk HPV (6, 11) In 2019, Gardasil/Gardasil9's global sales reached $3.737 billion, up 19 percent from the previous year both men and women are likely to develop HPV-induced pharynx cancer; For most people, HPV will clean itself up However, for those who fail to remove the virus, it can cause certain cancers Oral pharynx cancer can be caused by HPV infection in the mouth and throat, which includes the soft palate, the side wall of the throat and the back wall, the tonsils and the back third of the tongue according to a recently released model by the Centers for Disease Control and Prevention (CDC), HPV causes more oral cancer than cervical cancer, making it the most common HPV-related cancer in the United States original source: FDA approves Merck's GARDASIL 9 for the Prevention of HPV-About Head and Cancer